| CSFZX | DRLAX | CSFZX / DRLAX | |
| Total Expense Ratio | 0.84 | 1.30 | 65% |
| Annual Report Gross Expense Ratio | 0.84 | 1.50 | 56% |
| Fund Existence | 12 years | 20 years | - |
| Gain YTD | 10.660 | 12.844 | 83% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.38B | 337M | 705% |
| Annual Yield % from dividends | 3.16 | 2.42 | 131% |
| Returns for 1 year | 12.41 | 14.63 | 85% |
| Returns for 3 years | 36.59 | 41.99 | 87% |
| Returns for 5 years | 8.45 | 0.87 | 974% |
| Returns for 10 years | 49.22 | 22.42 | 220% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PJP | 130.03 | 1.14 | +0.89% |
| Invesco Pharmaceuticals ETF | |||
| CALF | 57.80 | 0.50 | +0.87% |
| Pacer US Small Cap Cash Cows 100 ETF | |||
| SEMI | 37.89 | N/A | +0.01% |
| Columbia Select Technology ETF | |||
| ANV | 25.39 | -0.07 | -0.27% |
| GraniteShares Autocallable NVDA ETF | |||
| CEE | 20.49 | -0.17 | -0.82% |
| Central and Eastern Europe Fund (The) | |||